This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DiFeo, A. Articles by Martignetti, J. A. Search for Related Content PubMed PubMed Citation Articles by DiFeo, A. Articles by Martignetti, J. A.

Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination

Authors' Affiliations: Departments of ¹ Human Genetics, ² Medicine, ³ Oncological Sciences, ⁴ Pathology, and ⁵ Pediatrics, Mount Sinai School of Medicine, New York, New York; ⁶ Department of Pathology, Regional Medical Center, San Jose, California; ⁷ Holden Comprehensive Cancer, Division of Gynecologic Oncology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa; and ⁸ National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: John A. Martignetti, Department of Human Genetics, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1498, New York, NY 10029. Phone: 212-659-6744; Fax: 212-849-2508; E-mail: John.Martignetti{at}mssm.edu.

Purpose: We investigated the role of the KLF6 tumor suppressor gene and its alternatively spliced isoform KLF6-SV1 in epithelial ovarian cancer (EOC).

Experimental Design: We first analyzed tumors from 68 females with EOC for KLF6 gene inactivation using fluorescent loss of heterozygosity (LOH) analysis and direct DNA sequencing and then defined changes in KLF6 and KLF6-SV1 expression levels by quantitative real-time PCR. We then directly tested the effect of KLF6 and KLF6-SV1 inhibition in SKOV-3 stable cell lines on cellular invasion and proliferation in culture and tumor growth, i.p. dissemination, ascites production, and angiogenesis in vivo using BALB/c nu/nu mice. All statistical tests were two sided.

Results: LOH was present in 59% of samples in a cell type–specific manner, highest in serous (72%) and endometrioid (75%) subtypes, but absent in clear cell tumors. LOH was significantly correlated with tumor stage and grade. In addition, KLF6 expression was decreased in tumors when compared with ovarian surface epithelial cells. In contrast, KLF6-SV1 expression was increased 5-fold and was associated with increased tumor grade regardless of LOH status. Consistent with these findings, KLF6 silencing increased cellular and tumor growth, angiogenesis, and vascular endothelial growth factor expression, i.p. dissemination, and ascites production. Conversely, KLF6-SV1 down-regulation decreased cell proliferation and invasion and completely suppressed in vivo tumor formation.

Conclusion: Our results show that KLF6 and KLF6-SV1 are associated with key clinical features of EOC and suggest that their therapeutic targeting may alter ovarian cancer growth, progression, and dissemination.

This article has been cited by other articles:

				A. DiFeo, F. Huang, J. Sangodkar, E. A. Terzo, D. Leake, G. Narla, and J. A. Martignetti KLF6-SV1 Is a Novel Antiapoptotic Protein That Targets the BH3-Only Protein NOXA for Degradation and Whose Inhibition Extends Survival in an Ovarian Cancer Model Cancer Res., June 1, 2009; 69(11): 4733 - 4741. [Abstract] [Full Text] [PDF]

				J. Holian, W. Qi, D. J. Kelly, Y. Zhang, E. Mreich, C. A. Pollock, and X.-M. Chen Role of Kruppel-like factor 6 in transforming growth factor-{beta}1-induced epithelial-mesenchymal transition of proximal tubule cells Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1388 - F1396. [Abstract] [Full Text] [PDF]

				A. DiFeo, L. Feld, E. Rodriguez, C. Wang, D. G. Beer, J. A. Martignetti, and G. Narla A Functional Role for KLF6-SV1 in Lung Adenocarcinoma Prognosis and Chemotherapy Response Cancer Res., February 15, 2008; 68(4): 965 - 970. [Abstract] [Full Text] [PDF]

				S. Natesampillai, J. Kerkvliet, P. C. K. Leung, and J. D. Veldhuis Regulation of Kruppel-like factor 4, 9, and 13 genes and the steroidogenic genes LDLR, StAR, and CYP11A in ovarian granulosa cells Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E385 - E391. [Abstract] [Full Text] [PDF]

				X. Wang, M. Zheng, G. Liu, W. Xia, P. J. McKeown-Longo, M.-C. Hung, and J. Zhao Kruppel-Like Factor 8 Induces Epithelial to Mesenchymal Transition and Epithelial Cell Invasion Cancer Res., August 1, 2007; 67(15): 7184 - 7193. [Abstract] [Full Text] [PDF]